ATE164071T1 - Magnesiumhaltiges arzneimittel mit verlängerter wirkstoffabgabe - Google Patents
Magnesiumhaltiges arzneimittel mit verlängerter wirkstoffabgabeInfo
- Publication number
- ATE164071T1 ATE164071T1 AT92912677T AT92912677T ATE164071T1 AT E164071 T1 ATE164071 T1 AT E164071T1 AT 92912677 T AT92912677 T AT 92912677T AT 92912677 T AT92912677 T AT 92912677T AT E164071 T1 ATE164071 T1 AT E164071T1
- Authority
- AT
- Austria
- Prior art keywords
- magnesium
- weight
- mgo
- parts
- source
- Prior art date
Links
- 238000013265 extended release Methods 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000011777 magnesium Substances 0.000 abstract 6
- 239000000203 mixture Substances 0.000 abstract 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 abstract 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 3
- 229910052749 magnesium Inorganic materials 0.000 abstract 3
- 229910001629 magnesium chloride Inorganic materials 0.000 abstract 2
- 230000007812 deficiency Effects 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- -1 fatty acid esters Chemical class 0.000 abstract 1
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 229920001600 hydrophobic polymer Polymers 0.000 abstract 1
- MJMDTFNVECGTEM-UHFFFAOYSA-L magnesium dichloride monohydrate Chemical class O.[Mg+2].[Cl-].[Cl-] MJMDTFNVECGTEM-UHFFFAOYSA-L 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9107141A FR2677546B1 (fr) | 1991-06-12 | 1991-06-12 | Composition therapeutique pour liberation prolonge de magnesium. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE164071T1 true ATE164071T1 (de) | 1998-04-15 |
Family
ID=9413736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92912677T ATE164071T1 (de) | 1991-06-12 | 1992-06-12 | Magnesiumhaltiges arzneimittel mit verlängerter wirkstoffabgabe |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0542979B1 (de) |
| JP (1) | JPH06503096A (de) |
| AT (1) | ATE164071T1 (de) |
| DE (1) | DE69224793T2 (de) |
| DK (1) | DK0542979T3 (de) |
| ES (1) | ES2117049T3 (de) |
| FR (1) | FR2677546B1 (de) |
| WO (1) | WO1992022305A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6887492B2 (en) | 2000-12-14 | 2005-05-03 | Leiner Health Services Corp. | Magnesium plus interactive agent delivery |
| FR2855412B1 (fr) * | 2003-05-27 | 2007-05-25 | Menvielle Bourg Fabienn Joanny | Composition a liberation prolongee de magnesium, et son application dans le domaine therapeutique, cosmetique et nutritionnel |
| FR2931359B1 (fr) | 2008-05-20 | 2012-12-21 | Menvielle Bourg Fabienne Joanny | Utilisation d'une matrice pour administration orale de magnesium a liberation prolongee, et composition contenant cette matrice |
| FR2931361B1 (fr) | 2008-05-20 | 2012-08-31 | Menvielle Bourg Fabienne Joanny | Systeme a base de magnesium et son utilisation en cosmetique |
| EP2813217A1 (de) | 2013-06-11 | 2014-12-17 | Fabienne Joanny Menvielle-Bourg | Zusammensetzung zur oralen Verabreichung von Magnesium in Verbindung mit einer Zusammensetzung zur Behandlung des Diabetes Typ 2 oder seiner Komplikationen |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422193A (en) * | 1974-07-26 | 1976-01-21 | Smith Kline French Lab | Pharmaceutical compositions |
| CH677612A5 (de) * | 1987-09-11 | 1991-06-14 | Ciba Geigy Ag | |
| GB8809421D0 (en) * | 1988-04-21 | 1988-05-25 | Fordonal Sa | Antacid compositions with prolonged gastric residence time |
| US5002774A (en) * | 1989-06-08 | 1991-03-26 | Erbamont, Inc. | Sustained release pharmaceutical tablet |
-
1991
- 1991-06-12 FR FR9107141A patent/FR2677546B1/fr not_active Expired - Fee Related
-
1992
- 1992-06-12 DK DK92912677T patent/DK0542979T3/da active
- 1992-06-12 ES ES92912677T patent/ES2117049T3/es not_active Expired - Lifetime
- 1992-06-12 WO PCT/FR1992/000534 patent/WO1992022305A1/fr not_active Ceased
- 1992-06-12 DE DE69224793T patent/DE69224793T2/de not_active Expired - Fee Related
- 1992-06-12 EP EP92912677A patent/EP0542979B1/de not_active Expired - Lifetime
- 1992-06-12 AT AT92912677T patent/ATE164071T1/de not_active IP Right Cessation
- 1992-06-12 JP JP5500766A patent/JPH06503096A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO1992022305A1 (fr) | 1992-12-23 |
| EP0542979B1 (de) | 1998-03-18 |
| DK0542979T3 (da) | 1999-01-04 |
| FR2677546B1 (fr) | 1994-01-21 |
| ES2117049T3 (es) | 1998-08-01 |
| JPH06503096A (ja) | 1994-04-07 |
| DE69224793T2 (de) | 1998-11-19 |
| DE69224793D1 (de) | 1998-04-23 |
| EP0542979A1 (de) | 1993-05-26 |
| FR2677546A1 (fr) | 1992-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2009890A1 (en) | Valproic acid | |
| MX171463B (es) | Sistema de dosificacion de liberacion sostenida y procedimiento para su preparacion | |
| IL85523A (en) | Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it | |
| HUP0300388A2 (hu) | Bevonó- és kötőanyag javított tárolási stabilitással rendelkező gyógyászati készítményekhez | |
| RU94022269A (ru) | Состав аэрозоля, находящийся под давлением | |
| DE69206214D1 (de) | Neue Arylethylaminderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen. | |
| IL111647A0 (en) | Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles, their preparation and pharmaceutical compositions containing them | |
| IL102759A0 (en) | Hydantoin derivatives,their preparation and pharmaceutical compositions containing them | |
| NZ244021A (en) | Benzylthiazolidinedione derivatives, preparation and pharmaceutical compositions thereof | |
| NZ240214A (en) | Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs | |
| GR3026369T3 (en) | Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist. | |
| RU94026856A (ru) | Ноотропное и транквилизирующее средство | |
| ZA917371B (en) | Calcium uptake inhibitors | |
| ES8207169A1 (es) | Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad. | |
| DE68906746D1 (de) | Psyllium enthaltende produkte. | |
| ATE164071T1 (de) | Magnesiumhaltiges arzneimittel mit verlängerter wirkstoffabgabe | |
| FR2712809B1 (fr) | Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide. | |
| NZ332655A (en) | Pharmaceutical compositions containing diclofenac and alkali metal bicarbonates | |
| US3594467A (en) | Long-lasting troche | |
| DE1292303T1 (de) | Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält | |
| JPS5781409A (en) | External plaster | |
| CA2357114A1 (en) | Use of melatonin in the manufacture of a medicament for treating attention deficit hyperactive disorder | |
| JPS5750914A (en) | Betamethasone external pharmaceutical | |
| JPS57200361A (en) | "indomethacin(r)" pharmaceutical with low irritant action | |
| ES2059260A1 (es) | Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |